Australia markets closed

Flaherty & Crumrine Preferred Income Fund Inc. (PFD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
10.11-0.01 (-0.10%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 129.94M
Enterprise value N/A
Trailing P/E 63.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)50.13
Price/book (mrq)0.92
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 30.30%
S&P500 52-week change 322.43%
52-week high 310.70
52-week low 38.53
50-day moving average 310.26
200-day moving average 39.84

Share statistics

Avg vol (3-month) 330.48k
Avg vol (10-day) 333.24k
Shares outstanding 512.85M
Implied shares outstanding 612.85M
Float 8N/A
% held by insiders 10.00%
% held by institutions 113.48%
Shares short (15 Apr 2024) 44.04k
Short ratio (15 Apr 2024) 40.15
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.03%
Shares short (prior month 15 Mar 2024) 44.41k

Dividends & splits

Forward annual dividend rate 40.7
Forward annual dividend yield 46.92%
Trailing annual dividend rate 30.70
Trailing annual dividend yield 36.90%
5-year average dividend yield 46.65
Payout ratio 4428.44%
Dividend date 330 Apr 2019
Ex-dividend date 422 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)30 Nov 2023

Profitability

Profit margin 12.15%
Operating margin (ttm)87.96%

Management effectiveness

Return on assets (ttm)3.69%
Return on equity (ttm)1.34%

Income statement

Revenue (ttm)15.86M
Revenue per share (ttm)1.23
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)1.93M
Diluted EPS (ttm)-1.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)91.1M
Total debt/equity (mrq)64.70%
Current ratio (mrq)3.37
Book value per share (mrq)10.96

Cash flow statement

Operating cash flow (ttm)7.73M
Levered free cash flow (ttm)5.53M